Sort
51,593 grants matching “hepatitis”
Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition
$588,464Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition
$588,464Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$588,460James A Stewart · University Of Wisconsin-Madison · U10 · FY2007 · CA
HBV-specific T cell immunity in HBV/HIV coinfection
$588,450Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R37 · FY2025 · AI
Amphiphilic Polycations for Nucleic Acid Delivery
$588,373David B Rozema · Mirus Bio Corporation · R44 · FY2007 · GM
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
$588,368Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2019 · CA
MOLECULAR BEACONS FOR RETROVIRAL DIAGNOSTICS
$588,336Public Health Research Institute · R01 · FY2002 · EB
Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid
$588,310Charles J Neighbors · New York University School Of Medicine · R33 · FY2023 · DA
Role of extracellular vesicles in the regulation of immunometabolism in obesity
$588,256Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for
$588,205Phillip Berman · University Of California Santa Cruz · R01 · FY2015 · DA
MRI-based Quantitative Susceptibility Mapping of Hepatic Iron Overload
$588,177Diego Hernando · University Of Wisconsin-Madison · R01 · FY2019 · DK
A Network &Dyad HIV Prevention Intervention for IDUs
$588,114Johns Hopkins University · R01 · FY2003 · DA
Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT
$588,104Mortimer Poncz · Children'S Hosp Of Philadelphia · R01 · FY2018 · HL
THERE HAS BEEN A GROWING APPRECIATION FOR THE BENEFITS OF USING NON-THERMAL TREATMENTS AS GREENER AND MORE ENERGY EFFICIENT PROCESSES FOR THE TREATMENT OF BEVERAGES WHEN COMPARED TO THERMAL TREATMENTS. AS A RESULT, THERE IS AN INCREASED INTEREST IN APPLYING ULTRAVIOLET (UV) LIGHT TECHNOLOGY IN THE TREATMENT OF BEVERAGES TO INACTIVATE BACTERIAL SPORES AND RESISTANT NON-ENVELOPED VIRUSES SUCH AS HEPATITIS A VIRUS (HAV) AND HUMAN NOROVIRUSES (HNOV), IN ADDITION TO PATHOGENIC AND SPOILAGE MICROORGANISMS. THIS PROJECT IS INTENDED TO ACHIEVE THESE GOALS AND BRIDGE EXISTING KNOWLEDGE GAPS BY ASSESSING THE SENSITIVITY OF TARGET FOODBORNE VIRUSES AND BACTERIAL SPORES TO UV AND DEVELOPING DOSE-RESPONSE CURVES (PASTEURIZED EQUIVALENT DOSE OR STERILIZED EQUIVALENT DOSE). RECENT PUBLISHED STUDIES HAVE DEMONSTRATED A HIGH RESISTANCE OF THESE ORGANISMS TO THERMAL PROCESSING, AND UV COULD BE AN IMPORTANT COMPLEMENTARY TREATMENT. THIS PROPOSAL IS TARGETED TO DEVELOP EMERGING FOODBORNE VIRAL PATHOGEN DISINFECTION METHODS FOR BEVERAGE TREATMENT AS WELL AS SPORE INACTIVATION. SYSTEMS DEVELOPED IN THIS PROJECT WILL BE A BREAKTHROUGH IN CURRENT PASTEURIZATION AND STERILIZATION PRACTICES FOR LIQUID FOODS IN THE UNITED STATES AND ARE LIKELY TO EXTEND TO FINDING SOLUTIONS FOR GLOBAL FOOD SAFETY ISSUES. THE PROJECT ALSO INTENDS TO ASSESS CONSUMER PERCEPTIONS AND ACCEPTANCE OF NON-THERMAL UV TECHNOLOGIES AND TO DEVELOP EDUCATIONAL PROGRAMMING FOR CONSUMERS BASED UPON SURVEY RESULTS. IN ADDITION, INTENSE EDUCATIONAL PROGRAMS FOR STUDENTS AT THE GRADUATE AND UNDER-GRADUATE LEVELS WILL BE IMPLEMENTED, AND EDUCATIONAL WORKSHOPS ON NEW FOOD SAFETY TECHNOLOGIES WILL BE HELD FOR FOOD SAFETY PROFESSIONALS AND EDUCATORS.
$588,085Tennessee State University · · FY2019 · National Institute of Food and Agriculture
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA
$587,980Amy Caroline Justice · Yale University · U01 · FY2017 · AA
Conceptual and mechanistic insights into the development of diet-induced obesity through disruption of hepatic circadian rhythms by the gut microbiome
$587,960Eugene B Chang · University Of Chicago · R01 · FY2021 · DK
Conceptual and mechanistic insights into the development of diet-induced obesity through disruption of hepatic circadian rhythms by the gut microbiome
$587,960Eugene B Chang · University Of Chicago · R01 · FY2022 · DK
Conceptual and mechanistic insights into the development of diet-induced obesity through disruption of hepatic circadian rhythms by the gut microbiome
$587,960Eugene B Chang · University Of Chicago · R01 · FY2020 · DK
Novel strategies to accelerate repair of drug-induced hepatotoxicity
$587,852James P Luyendyk · Michigan State University · R01 · FY2023 · DK
Vaccine and Treatment Evaluation Unit at Saint Louis University
$587,832Daniel F. Hoft · Saint Louis University · UM1 · FY2022 · AI
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$587,815Joannes B Hoek · Thomas Jefferson University · R01 · FY2018 · AA
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
$587,665Robert Turner Schooley · University Of California, San Diego · R01 · FY2011 · AI
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
$587,655Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2015 · AI
Project 2: PREVENT Preclinical safety and efficacy studies
$587,628Kenneth E Palmer · University Of Louisville · U19 · FY2014 · AI
Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for
$587,526Phillip Berman · University Of California Santa Cruz · R01 · FY2016 · DA